(Q47730967)

5 February 2018

meta-analysis

0 references

title

Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a meta-analysis (English)

1 reference

5 February 2018

1 reference

Robert A Hamilton

1

1 reference

5 February 2018

Michael P Kane

series ordinal

2

1 reference

5 February 2018

Jason Demers

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

5 February 2018

published in

Pharmacotherapy

1 reference

5 February 2018

volume

23

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

909-915

1 reference

5 February 2018

Clinical practice. Nephropathy in patients with type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Preventing end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Diabetes trends in the U.S.: 1990-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.7.909.32726

10.1592/PHCO.23.7.909.32726

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

release_h5ttoj73anhz5onjuomxw2azce

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h5ttoj73anhz5onjuomxw2azce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

5 February 2018